Literature DB >> 22742623

Linezolid for multidrug-resistant tuberculosis.

Kwok-Chiu Chang1, Chi-Chiu Leung, Charles L Daley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22742623     DOI： 10.1016/S1473-3099(12)70137-8

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  3 in total

1.  Comparison of Effectiveness Between Delamanid and Bedaquiline Among Patients with Multidrug-Resistant Tuberculosis: A Markov Model Simulation Study.

Authors:  Ji-Hye Byun; Jae-A Park; Hye-Rim Kang; Ju-Young Shin; Eui-Kyung Lee
Journal:  Clin Drug Investig       Date:  2016-11       Impact factor: 2.859

Review 2.  Rising to the challenge: new therapies for tuberculosis.

Authors:  Emily B Wong; Keira A Cohen; William R Bishai
Journal:  Trends Microbiol       Date:  2013-06-11       Impact factor: 17.079

3.  Linezolid for drug-resistant pulmonary tuberculosis.

Authors:  Bhagteshwar Singh; Derek Cocker; Hannah Ryan; Derek J Sloan
Journal:  Cochrane Database Syst Rev       Date:  2019-03-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.